Paper26323422
Mucoadhesive Chitosan Derivatives as Novel Drug Carriers.
Islam MA and 10 others. Curr Pharm Des, 2015. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Mucoadhesive Chitosan Derivatives as Novel Drug Carriers. Papers, record 26323422. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26323422
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chitosan | Major topic |
| Drug Carriers | Major topic |
| Mucous Membrane | Major topic |
| Adhesiveness | |
| Animals | |
| Drug Delivery Systems | |
| Humans | |
| Mucins | |
| Nanostructures |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40337306 | From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/40337306 | PubMed |
| 38887635 | Chitosan alchemy: transforming tissue engineering and wound healing. | RSC Adv | 2024 | https://conductscience.org/library/papers/38887635 | PubMed |
| 38475368 | Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach. | Polymers (Basel) | 2024 | https://conductscience.org/library/papers/38475368 | PubMed |
| 37964169 | Chitosan nanoparticles encapsulating farnesol evaluated in vivo against Candida albicans. | Braz J Microbiol | 2024 | https://conductscience.org/library/papers/37964169 | PubMed |
| 37896217 | Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37896217 | PubMed |
| 37177171 | Optimization of a Mucoadhesive Vaginal Gel Containing Clotrimazole Using a D-Optimal Experimental Design and Multivariate Analysis. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/37177171 | PubMed |
| 37102920 | Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features. | Gels | 2023 | https://conductscience.org/library/papers/37102920 | PubMed |
| 36678762 | Synthesis and Characterization of Innovative Microgels Based on Polyacrylic Acid and Microalgae Cell Wall and Their Potential as Antigen Delivery Vehicles. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36678762 | PubMed |
| 36616453 | The Use of Polymers to Enhance Post-Orthodontic Tooth Stability. | Polymers (Basel) | 2022 | https://conductscience.org/library/papers/36616453 | PubMed |
| 36593953 | Recent advances in the medical applications of hemostatic materials. | Theranostics | 2023 | https://conductscience.org/library/papers/36593953 | PubMed |
| 36466349 | The application of nanotechnology in treatment of Alzheimer's disease. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36466349 | PubMed |
| 35875806 | Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35875806 | PubMed |
| 35056788 | Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment. | Molecules | 2022 | https://conductscience.org/library/papers/35056788 | PubMed |
| 34992363 | Protective Effects of Chitosan-Bilirubin Nanoparticles Against Ethanol-Induced Gastric Ulcers. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/34992363 | PubMed |
| 34940319 | New Formulations Loading Caspofungin for Topical Therapy of Vulvovaginal Candidiasis. | Gels | 2021 | https://conductscience.org/library/papers/34940319 | PubMed |
| 34926557 | A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems. | Front Nutr | 2021 | https://conductscience.org/library/papers/34926557 | PubMed |
| 34771955 | Fluorescent Chitosan Modified with Heterocyclic Aromatic Dyes. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34771955 | PubMed |
| 34304387 | Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems. | Tissue Eng Regen Med | 2021 | https://conductscience.org/library/papers/34304387 | PubMed |
| 34203816 | Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34203816 | PubMed |
| 33925332 | A Review on Current Trends of Polymers in Orthodontics: BPA-Free and Smart Materials. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/33925332 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26323422
GET https://conductscience.org/api/papers/v1/26323422/cited_by?page=2